Literature DB >> 21872234

Stillbirth rate at an emerging tertiary health institution in Enugu, southeast Nigeria.

Euzebus C Ezugwu1, Hyacinth E Onah, Hygenius U Ezegwui, Chidi Nnaji.   

Abstract

OBJECTIVES: To determine the stillbirth rate and factors predisposing to a stillbirth delivery at a teaching hospital in Nigeria, with the aim of identifying solutions.
METHOD: A descriptive study of all stillbirths delivered at Enugu State University of Science and Technology Teaching Hospital, Parklane, Nigeria between January 1 and December 31, 2009. The sociodemographic characteristics of the mothers were documented and the possible causes of death were analyzed.
RESULTS: There were 153 stillbirths and 2064 total deliveries, giving a stillbirth rate of 74 per 1000 deliveries. Of the stillbirths, 52.3% were fresh and 47.7% were macerated. Women who had not received prenatal care had a significantly higher stillbirth rate (P<0.05). The most likely cause of a macerated stillbirth was a hypertensive disorder of pregnancy, whereas the likely causes of fresh stillbirths were labor-related. The "3 levels of delay" and injudicious use of oxytocin in labor contributed to the intrapartum stillbirths (P<0.05).
CONCLUSION: The stillbirth rate recorded in the study institution is unacceptably high. Appropriate prenatal care, timely intervention, and prompt and appropriate intrapartum care are key to achieving a reduction in the stillbirth rate.
Copyright © 2011 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21872234     DOI: 10.1016/j.ijgo.2011.05.028

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  8 in total

Review 1.  Maternal death and obstetric care audits in Nigeria: a systematic review of barriers and enabling factors in the provision of emergency care.

Authors:  Julia Hussein; Atsumi Hirose; Oluwatoyin Owolabi; Mari Imamura; Lovney Kanguru; Friday Okonofua
Journal:  Reprod Health       Date:  2016-04-22       Impact factor: 3.223

2.  Stillbirths in urban Guinea-Bissau: A hospital- and community-based study.

Authors:  Morten Bjerregaard-Andersen; Najaaraq Lund; Anne Sofie Pinstrup Joergensen; Frida Starup Jepsen; Holger Werner Unger; Mama Mane; Amabelia Rodrigues; Staffan Bergström; Christine Stabell Benn
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

3.  A prospective study of twinning and perinatal mortality in urban Guinea-Bissau.

Authors:  Morten Bjerregaard-Andersen; Najaaraq Lund; Frida Staarup Jepsen; Luis Camala; Margarida Alfredo Gomes; Kaare Christensen; Lene Christiansen; Dorte Møller Jensen; Peter Aaby; Henning Beck-Nielsen; Christine Stabell Benn; Morten Sodemann
Journal:  BMC Pregnancy Childbirth       Date:  2012-12-05       Impact factor: 3.007

4.  Determinants of stillbirths in katsina, Nigeria: a hospital-based study.

Authors:  Bello M Suleiman; H M Ibrahim; N Abdulkarim
Journal:  Pediatr Rep       Date:  2015-03-27

5.  Baird-Pattinson Aetiological Classification and Phases of Delay Contributing to Stillbirths in a Nigerian Tertiary Hospital.

Authors:  Jacob Olumuyiwa Awoleke; Abiodun Idowu Adanikin
Journal:  J Pregnancy       Date:  2016-01-14

6.  An investigation of the stillbirths at a tertiary hospital in Limpopo province of South Africa.

Authors:  Sam Thembelihle Ntuli; Ntambwe Malangu
Journal:  Glob J Health Sci       Date:  2012-09-24

7.  Case review of perinatal deaths at hospitals in Kigali, Rwanda: perinatal audit with application of a three-delays analysis.

Authors:  Aimable Musafili; Lars-Åke Persson; Cyprien Baribwira; Jessica Påfs; Patrick Adam Mulindwa; Birgitta Essén
Journal:  BMC Pregnancy Childbirth       Date:  2017-03-11       Impact factor: 3.007

8.  The trend and characteristics of stillbirth delivery in a university teaching hospital in Lagos, Nigeria.

Authors:  Adeyemi Adebola Okunowo; Shakirat Tinuola Smith-Okonu
Journal:  Ann Afr Med       Date:  2020 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.